Francisco Mojica

Francisco Mojica. Francisco Juan Martínez Mojica is a Spanish microbiologist and professor at the University of Alicante, renowned for his pioneering discovery of the CRISPR sequences in archaea. His foundational research, conducted in the 1990s and early 2000s, identified these repetitive DNA structures as part of a prokaryote immune system, a breakthrough that laid the essential groundwork for the revolutionary CRISPR gene editing technology. Often described as the "father of CRISPR," his work has transformed biotechnology, genetics, and medicine, earning him numerous prestigious international accolades.

Early life and education

Francisco Mojica was born in Elche, within the Valencian Community of Spain. He developed an early interest in biology, which led him to pursue higher education at the University of Alicante. There, he completed his undergraduate degree in biology before earning his PhD in microbiology in 1993, with a dissertation focused on halophilic microorganisms from the salt flats near Santa Pola. His doctoral research, supervised by renowned scientists, involved studying the genomics of Haloferax mediterranei, an archaeon adapted to extreme salinity. This work provided the critical context for his subsequent, fateful observations. Following his PhD, he secured a postdoctoral position at the University of Oxford in the United Kingdom, where he further honed his skills in molecular biology techniques before returning to Alicante to continue his academic career.

Discovery of CRISPR

The pivotal discovery occurred while Mojica was analyzing the genome of Haloferax mediterranei in the mid-1990s. He identified unusual, regularly spaced palindromic repeats in the organism's DNA, a finding he later observed in other bacteria and archaea like Escherichia coli and Mycobacterium tuberculosis. Intrigued by these mysterious sequences, which were noted but unexplained in the scientific literature, including in research on Yersinia pestis, he dedicated his laboratory to unraveling their function. In 2002, after extensive bioinformatics analysis, he and his team published a seminal paper proposing that these clusters, which he later named CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), constituted an adaptive immune system in prokaryotes. This hypothesis, suggesting the sequences stored memories of past viral infections from bacteriophages like lambda phage, was groundbreaking and initially met with skepticism before being validated by researchers such as Philippe Horvath at Danisco.

Research and career

Upon establishing his independent research group at the University of Alicante, Mojica focused on elucidating the molecular mechanism of the CRISPR-Cas system. His work demonstrated how Cas proteins utilized CRISPR RNA to target and cleave invading genetic material, providing a definitive explanation for this form of acquired immunity. This fundamental research directly enabled later applied discoveries by Emmanuelle Charpentier, Jennifer Doudna, and Feng Zhang, who harnessed the system for programmable genome editing. Throughout his career, Mojica has continued to investigate the diversity and evolution of CRISPR systems across the microbial world, contributing significantly to the fields of microbial ecology and evolutionary biology. He maintains an active laboratory and teaches genetics and microbiology, mentoring the next generation of scientists in Spain.

Awards and recognition

Mojica's foundational contributions have been recognized with many of the world's top scientific awards. He received the BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category in 2016. In 2017, he was a co-recipient of the prestigious Albany Medical Center Prize, one of the largest awards in medicine in the United States. Other notable honors include the Jaime I Award for Basic Research in Spain, the Michele Auger Award from the Canadian Society for Chemistry, and the Carlos Jiménez Díaz Prize. He has also been awarded the Hubert Rehm Award and the Knight of the Order of the Legion of Honour from France. Despite being a frequent nominee for the Nobel Prize in Chemistry, his role as the discoverer of the biological phenomenon is universally acclaimed within the scientific community.

Personal life

Francisco Mojica is known to be a private individual who maintains a strong connection to his hometown region of Elche and the University of Alicante. Colleagues describe him as a humble and dedicated scientist who was driven by pure curiosity rather than the pursuit of fame or commercial application. His passion for microbiology extends beyond the laboratory, and he is an advocate for fundamental scientific research. He continues to live and work in Alicante, contributing to the vibrant scientific culture of Spain while witnessing the global impact of his early discoveries on fields from agricultural science to gene therapy for diseases like sickle cell disease.

Category:Spanish microbiologists Category:CRISPR researchers Category:University of Alicante alumni Category:University of Alicante faculty Category:1963 births Category:Living people